About this trial
This clinical trial compares the effect a financial intervention, called Financial Compass, to usual care in identifying and addressing financial hardship in patients with head and neck cancer. Previous research has shown that head and neck cancer patients experiencing financial hardship have decreased overall and cancer specific survival. Using a financial intervention, Financial Compass, may be more effective than usual care in identifying and addressing financial hardship in patients with head and neck cancer.
Eligibility criteria
Qualifiers
They have been diagnosed with head and neck cancer
Screen positive for financial hardship on the validated Comprehensive Score for Financial Toxicity (COST) measure
Are able to participate in English or Spanish
Disqualifiers
Adults unable to complete the process of informed consent
Adults whose primary language is not English or Spanish
Individuals who are not yet adults (i.e., infants, children, teenagers)
Unwilling or unable to follow protocol requirements
Trial design
Treatments tested in this trial
- Best Practice
- Discussion
- Financial Navigation
- Survey Administration